Trimethoprim/sulfamethoxazole pharmacodynamics against Stenotrophomonas maltophilia in the in vitro chemostat model.
Maxwell J LaskoJennifer L Tabor-RennieYasmeen AbouelhassanJoseph L KutiPublished in: The Journal of antimicrobial chemotherapy (2022)
In this in vitro chemostat model, trimethoprim/sulfamethoxazole monotherapy, even at higher doses, achieved limited activity against susceptible S. maltophilia.